Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cerilliant
Farmers Insurance
Daiichi Sankyo
Cantor Fitzgerald
Chinese Patent Office
Medtronic
Johnson and Johnson
Boehringer Ingelheim

Generated: December 16, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR GLYBURIDE AND METFORMIN HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Glyburide And Metformin Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00035542 A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes. Completed Bristol-Myers Squibb Phase 3 The purpose of this clinical research study is to see if Glucovance, a medication currently approved for use in adults with type 2 diabetes, can control type 2 diabetes safely and effectively in children 9 to 16 years of age.
NCT00035568 A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes Completed Bristol-Myers Squibb Phase 4 The purpose of this clinical research study is to support earlier observations that Glucovance controls glucose levels after a mean, and improves overall glucose control better than metformin or glyburide therapy alone in adults with type 2 diabetes.
NCT00194896 Preferred Treatment of Type 1.5 Diabetes Completed GlaxoSmithKline N/A The purpose of this research was to test whether one treatment was superior over another in the management of type 1.5 diabetes. Specifically we tested recently diagnosed antibody positive type 2 diabetic patients to determine whether treatment with rosiglitazone results in greater preservation of beta cell function compared to treatment with glyburide.
NCT00194896 Preferred Treatment of Type 1.5 Diabetes Completed Seattle Institute for Biomedical and Clinical Research N/A The purpose of this research was to test whether one treatment was superior over another in the management of type 1.5 diabetes. Specifically we tested recently diagnosed antibody positive type 2 diabetic patients to determine whether treatment with rosiglitazone results in greater preservation of beta cell function compared to treatment with glyburide.
NCT00194896 Preferred Treatment of Type 1.5 Diabetes Completed University of Washington N/A The purpose of this research was to test whether one treatment was superior over another in the management of type 1.5 diabetes. Specifically we tested recently diagnosed antibody positive type 2 diabetic patients to determine whether treatment with rosiglitazone results in greater preservation of beta cell function compared to treatment with glyburide.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Glyburide And Metformin Hydrochloride

Condition Name

Condition Name for Glyburide And Metformin Hydrochloride
Intervention Trials
Healthy 5
Gestational Diabetes 5
Gestational Diabetes Mellitus 3
Diabetes Mellitus, Type 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Glyburide And Metformin Hydrochloride
Intervention Trials
Diabetes Mellitus 16
Diabetes Mellitus, Type 2 9
Diabetes, Gestational 9
Fractures, Bone 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Glyburide And Metformin Hydrochloride

Trials by Country

Trials by Country for Glyburide And Metformin Hydrochloride
Location Trials
United States 112
United Kingdom 26
Canada 18
Germany 14
Italy 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Glyburide And Metformin Hydrochloride
Location Trials
Texas 8
Illinois 5
California 4
Washington 4
Pennsylvania 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Glyburide And Metformin Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Glyburide And Metformin Hydrochloride
Clinical Trial Phase Trials
Phase 4 5
Phase 3 6
Phase 2 1
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Glyburide And Metformin Hydrochloride
Clinical Trial Phase Trials
Completed 18
Recruiting 2
Unknown status 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Glyburide And Metformin Hydrochloride

Sponsor Name

Sponsor Name for Glyburide And Metformin Hydrochloride
Sponsor Trials
GlaxoSmithKline 5
Actavis Inc. 3
Bristol-Myers Squibb 2
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Glyburide And Metformin Hydrochloride
Sponsor Trials
Other 20
Industry 14
NIH 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Healthtrust
Medtronic
Harvard Business School
Moodys
Daiichi Sankyo
Baxter
UBS
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.